ArticleJournal of family medicine and primary care2024

A study of SGLT2 inhibitors on levels of plasma atherogenesis biomarkers in diabetes.

Naveenkumar Nallathambi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.